Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S L Huber

Showing results (11-20 of 16) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 16 results.
Hospital Formulary|December 11, 1984
Drug usage guidelines, Part 2: Analysis of program outcomeR A Patry, S L Huber, H D Hudson, et al.
Hospital Formulary|March 11, 1985
Drug usage guidelines, Part 3: assessment of acceptance of the programR A Patry, S L Huber, G Rice, et al.
Cancer|March 26, 1999
The rapid assessment of fatigue severity in cancer patients: use of the Brief Fatigue InventoryT R Mendoza, X S Wang, C S Cleeland, et al.
Annals of Internal Medicine|October 1, 1996
Cost-effectiveness of interferon-alpha and conventional chemotherapy in chronic myelogenous leukemiaM W Kattan, Y Inoue, F J Giles, et al.
Cancer|November 1, 1993
The economic impact of therapy on cancer patientsG P Murphy, J Prestifilippo, K Antman, et al.
Cancer|November 1, 1993
The impact of clinical trial protocols on patient care systemsW Lawrence, K Antman, H P Freeman, et al.
Pageof 2

Showing results (11-20 of 16) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 16 results.
Hospital Formulary|December 11, 1984
Drug usage guidelines, Part 2: Analysis of program outcomeR A Patry, S L Huber, H D Hudson, et al.
Hospital Formulary|March 11, 1985
Drug usage guidelines, Part 3: assessment of acceptance of the programR A Patry, S L Huber, G Rice, et al.
Cancer|March 26, 1999
The rapid assessment of fatigue severity in cancer patients: use of the Brief Fatigue InventoryT R Mendoza, X S Wang, C S Cleeland, et al.
Annals of Internal Medicine|October 1, 1996
Cost-effectiveness of interferon-alpha and conventional chemotherapy in chronic myelogenous leukemiaM W Kattan, Y Inoue, F J Giles, et al.
Cancer|November 1, 1993
The economic impact of therapy on cancer patientsG P Murphy, J Prestifilippo, K Antman, et al.
Cancer|November 1, 1993
The impact of clinical trial protocols on patient care systemsW Lawrence, K Antman, H P Freeman, et al.
Pageof 2